Topical application of dexamethasone to brain tumour bed retains its biological effectiveness in controlling peritumoural brain oedema, possibly through the oncolytic mechanism (cytostatic effect). The question rises, whether the systemic administration of dexamethasone can be duplicated with dexamethasone topically to the brain tumour bed.
|Original language||English (US)|
|Number of pages||2|
|Journal||Acta neurochirurgica. Supplementum|
|State||Published - 1990|
ASJC Scopus subject areas
- Clinical Neurology